RVMD Revolution Medicines, Inc. | US76155X1000
Financials
Trends
Details
| Breakdown | 31.12.2027 | 31.12.2026 | Change % |
|---|---|---|---|
| Total Revenue | 881.228.590 | 103.253.490 | 753.46% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | -5,80 | -8,07 | 28.10% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 17 | 19 | 10.53% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |